Ophthalmic fluid delivery device and method of operation
The present invention provides an ophthalmic fluid delivery device adapted to deliver an ophthalmic fluid in the form of a mist to an ocular region of a patient. The ophthalmic fluid delivery device comprises a nozzle defining an aperture through which the ophthalmic fluid can flow and at least one shutter positioned proximate to the aperture of the nozzle. The shutter is mounted for movement with respect to the aperture of the nozzle between an open position permitting flow of the ophthalmic fluid through the aperture of the nozzle and a closed position at least partially covering the aperture. A shutter actuator is positioned proximate to the shutter. The shutter actuator is mounted for movement with respect to the nozzle, and the shutter actuator is coupled to the shutter such that the movement of the shutter actuator moves the shutter between the open position and the closed position.
1. An ophthalmic fluid delivery device adapted to deliver an ophthalmic fluid in the form of a mist to an ocular region of a patient from a reservoir containing the ophthalmic fluid, the ophthalmic fluid delivery device comprising:
a body defining a cavity sized to accommodate a reservoir;
a reservoir connected to said body and disposed within said cavity, wherein said reservoir contains an ophthalmic fluid disposed therein;
propulsion means for transmitting said ophthalmic fluid from said reservoir to a discharge plate, wherein transmission of said ophthalmic fluid across said discharge plate generating a plume of ophthalmic fluid along a direction directly toward said eye;
a nozzle assembly coupled to said body proximate said cavity, said nozzle assembly being configured to deliver said plume directly along a direction directly toward said eye, wherein said plume of ophthalmic fluid travels, without being subject to a dynamic force generated by a mechanical device of said ophthalmic fluid delivery system that is physically separate from said propulsion means, from said discharge plate to said eye and at said eye has a momentum that has a magnitude that is insufficient to trigger at least one of an ocular blink reflex and a lacrimation reflex of said eye; and
an aperture defined by said body adjacent said cavity defined by said body, said aperture being positioned to permit visualization of said reservoir from outside said body when said reservoir is positioned within said cavity of said body;
wherein the body comprises a proximal end and a distal end;
the discharge plate is disposed at the distal end;
the discharge plate includes a plurality of openings extending therethrough;
the aperture comprises a window;
the window is substantially translucent or transparent;
the ophthalmic fluid is discharged from the discharge plate at a velocity of between approximately 4 and 30 centimeters per second;
the ophthalmic fluid is discharged from the discharge plate at a rate of between approximately 2 and 10 microliters per second; and
the ophthalmic fluid discharged from the discharge plate has average particle sizes between approximately 0.5 and 10 microns in diameter.
2. The ophthalmic fluid delivery device according to claim 1 , said body having a door movable to an open position to facilitate access to said cavity.
3. The ophthalmic fluid delivery device according to claim 2 , said door being slidably movable with respect to said cavity.
4. The ophthalmic fluid delivery device according to claim 2 , said door being removable from said body.
5. The ophthalmic fluid delivery device according to claim 2 , said aperture being defined by said door.
6. The ophthalmic fluid delivery system according to claim 1 , wherein the ophthalmic fluid is selected from the group consisting of mydriatics/cycloplegics, anesthetics, flourescein, flourescein/anesthetic combinations, mydriatic reversal agents, ophthalmic decongestants, ophthalmic lubricants, and glaucoma medications.
7. The ophthalmic fluid delivery system according to claim 6 , wherein the glaucoma medications are selected from the group consisting of prestaglandins, beta blockers, alpha adrenergic agents, carbonic anhydrase inhibitors, and miotics.
8. The ophthalmic fluid delivery system according to claim 1 , wherein the plume of ophthalmic fluid has a volume that can entirely be retained by the eye.
9. The ophthalmic fluid delivery system of claim 1 , wherein the plume of ophthalmic fluid contains an amount of ophthalmic medicine and the momentum of the plume is such that substantially all of the amount of ophthalmic medicine is received and retained by the human eye.
10. The ophthalmic fluid delivery device according to claim 1 , wherein said substantially translucent or transparent window comprises volume graduation markings.
11. The ophthalmic fluid delivery device according to claim 1 , further comprising a label affixed to said substantially translucent or transparent window.
12. The ophthalmic fluid delivery device according to claim 11 , wherein indicia is included on said label, wherein said indicia is selected from the group consisting of company name, logo and color coding.